Bent Frandsen
Algemeen Directeur bij EXPRES2ION BIOTECH HOLDING AB
Actieve functies van Bent Frandsen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
EXPRES2ION BIOTECH HOLDING AB | Algemeen Directeur | 20-12-2019 | - |
Investor Relations Contact | 01-01-2016 | - | |
Corporate Officer/Principal | 01-01-2016 | 20-12-2019 | |
Adaptvac ApS | Directeur/Bestuurslid | 01-01-2017 | - |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Algemeen Directeur | - | - |
Loopbaan van Bent Frandsen
Eerdere bekende functies van Bent Frandsen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - | - |
Opleiding van Bent Frandsen
Copenhagen Business School | Graduate Degree |
Statistieken
Internationaal
Denemarken | 6 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Investor Relations Contact | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
EXPRES2ION BIOTECH HOLDING AB | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
Adaptvac ApS |
- Beurs
- Insiders
- Bent Frandsen
- Ervaring